Kontafarma China Holdings Ltd (1312.HK) HKSE
0.03
+0(+0.00%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Kontafarma China Holdings Ltd
Sector
Basic Materials
Industry
Construction Materials
Employees
714
First IPO Date
January 18, 2012
Key Executives
| Name | Title | Pay | Year Born |
| Feifei Wang | Executive Chairman & President | 540,000 | 1987 |
| Zixiu Guo | Financial Controller & Executive Director | 984,000 | 1989 |
| Jiankun Liu | Executive Director | 0 | N/A |
| Lok Tung Chan | Company Secretary | 0 | N/A |
| Jie Zhang | Chief Operating Officer | 0 | N/A |
| Limin Wang | Chairman of the Board & President | 0 | 1976 |
| Xuyang Han | Secretary | 0 | 1990 |
| Shouwen Ge | VP of Group & Executive Director | 0 | 1978 |
Description
Kontafarma China Holdings Ltd. engages in the manufacture and sale of cement. It operates through the following segments: Pharmaceutical and Fitness Business. The Pharmaceutical Business segment involves in manufacture and sales of prescription drugs and laboratory related products. The Fitness Business segment includes the operation of fitness centers and provide consultation services for fitness and health activities and operate the franchise business for royalty fee income. The company was founded on March 21, 2011 and is headquartered in Hong Kong.
